An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS

• Status: Completed
• Trial end date: 1969-12-31

Summary

To evaluate the safety and tolerance of cidofovir (HPMPC) infusions in AIDS patients with relapsing cytomegalovirus (CMV) retinitis. To determine the time to retinitis progression in this patient population. To evaluate the impact of cidofovir therapy on visual acuity.

• Phase: N/A

Details

• Lead Sponsor: Gilead Sciences
• Treatments: Cidofovir; Probenecid